| Renal compartment–specific genetic variation analyses identify new pathways in chronic kidney disease C Qiu, S Huang, J Park, YS Park, YA Ko, MJ Seasock, JS Bryer, XX Xu, ... Nature medicine 24 (11), 1721-1731, 2018 | 214 | 2018 |
| Monkeypox emerges on a global scale: a historical review and dermatologic primer J Bryer, EE Freeman, M Rosenbach Journal of the American Academy of Dermatology 87 (5), 1069-1074, 2022 | 77 | 2022 |
| Granulomatous dermatitis associated with rubella virus infection in an adult with immunodeficiency BE Shields, L Perelygina, S Samimi, P Haun, T Leung, E Abernathy, ... JAMA dermatology 157 (7), 842-847, 2021 | 25 | 2021 |
| Screening drugs for kidney disease: targeting the podocyte JS Bryer, K Susztak Cell Chemical Biology 25 (2), 126-127, 2018 | 16 | 2018 |
| Responsiveness to change and establishment of the minimal clinically important difference for the cutaneous sarcoidosis activity and morphology instrument MH Noe, JM Gelfand, JS Bryer, SN Price, MA Judson, M Rosenbach JAMA dermatology 156 (1), 98-99, 2020 | 10 | 2020 |
| Identification of a neutrophil-specific PIK3R1 mutation facilitates targeted treatment in a patient with Sweet syndrome S Bhattacharya, S Basu, E Sheng, C Murphy, J Wei, AE Kersh, CA Nelson, ... The Journal of Clinical Investigation 133 (1), 2023 | 8 | 2023 |
| Monkeypox emerges on a global scale: A historical review and dermatologic primer JS Bryer, EE Freeman, M Rosenbach Journal of the American Academy of Dermatology 88 (5), e259, 2022 | 8 | 2022 |
| A Phase 1 trial of targeted DSG3-CAART cell therapy in mucosal-dominant pemphigus vulgaris (mPV) patients: early cohort data DJ Chang, S Basu, D Porter, M Abedi, WK Weng, R Micheletti, ... MOLECULAR THERAPY 30 (4), 373-373, 2022 | 3 | 2022 |
| A prospective comparison of cutaneous sarcoidosis disease response to immunomodulatory and immunosuppressive therapies P Sharma, JS Bryer, S Price, MH Noe, M Rosenbach Journal of the American Academy of Dermatology 82 (6), 1546-1548, 2020 | 2 | 2020 |
| Penicillin allergy evaluation in hospitalized patients with hematologic malignancy VM Patel, B Chu, KW Hamilton, C Bellamy, C Harker, JS Bryer, B Shields, ... Antimicrobial Stewardship & Healthcare Epidemiology 3 (1), e92, 2023 | 1 | 2023 |
| 1548 Identification of a neutrophil-specific PIK3R1 mutation facilitates targeted treatment in a patient with sweet syndrome S Bhattacharya, S Basu, E Sheng, J Wei, A Kersh, C Nelson, J Bryer, ... Journal of Investigative Dermatology 143 (5), S266, 2023 | | 2023 |
| LB1040 Treatment of sweet syndrome by molecular identification of PIK3R1 mutation S Bhattacharya, E Sheng, C Murphy, J Wei, A Kersh, C Nelson, J Bryer, ... Journal of Investigative Dermatology 142 (8), B37, 2022 | | 2022 |
| P171 IMPLEMENTATION OF A PENICILLIN SKIN TESTING SERVICE IN INPATIENTS WITH HEMATOLOGIC MALIGNANCIES B Chu, V Patel, J Bryer, K Hamilton, O Fadugba, R Micheletti Annals of Allergy, Asthma & Immunology 127 (5), S49-S50, 2021 | | 2021 |
| A Phase 1 trial of desmoglein 3 chimeric autoantibody receptor T cells (DSG3-CAART) for targeted B cell depletion in patients with mucosal-dominant pemphigus vulgaris: The … E Maverakis, RG Micheletti, DL Porter, M Abedi, L Downing, JS Bryer, ... | | |
Matthew J SeasockBaylor College of MedicineAdresse e-mail validée de bcm.edu